U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

Read also:

• Israel says Iran was racing toward a bomb. US intelligence says it was years away - CNN
• US growth likely to slow to 1.6% this year, hobbled by Trump's trade wars, OECD says - ABC News
• How do I explain to my husband that my 19-year-old son has accidentally gotten me pregnant?
• Fermenting legume pulses increases antioxidant and antidiabetic properties, study finds - Phys.org
• What are some of the greatest marketing disasters in history?
• Sydney Sweeney and the business of being hot - Yahoo
• Heavy rains suspend play at US Open, raising the possibility of a Monday finish to the final round - CNN
• How does Arab culture and values differ from western culture and values?
• How do I cope with the fact that I will never have a girlfriend?
• After the recent controversy over Ghibli art, many are saying that the artist has no future while others say, that people prefer human art when compared to AI art. What's your opinion on it?
• Thousands of Netflix fans gather for Tudum - TechCrunch
• These are the 10 open source Android apps I install on every new phone - Android Authority
• Apple’s Liquid Glass design is paving the way for AR glasses - TechCrunch